Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca_plaque

Strong showing for AZ asthma drug, but diabetes treatment flops

May 23, 2017
Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes

AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …

News
astrazeneca_logo_building

AstraZeneca sells off rights to beta-blocker for $300 million

May 22, 2017
Sales and Marketing AstraZeneca, Recordati, Seloken

AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …

News
astrazeneca_building_white

AZ launches lawsuit against former executive for defecting to GSK

May 17, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …

News
astrazeneca_building_white

AZ asthma drug falls short in Phase 3 study

May 10, 2017
Research and Development AstraZeneca, asthma, tralokinumab

AstraZeneca and its global biologics research and development arm MedImmune have announced that asthma treatment tralokinumab has failed to achieve …

News
astrazeneca_sign_sky

Potential blockbuster AZ immunotherapy secures FDA approval

May 2, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, bladder cancer, darzalex

The FDA has granted accelerated approval to AstraZeneca’s (AZ) immunotherapy therapy Imfinzi (durvalumab) for the treatment of locally advanced or …

News
astrazeneca_building_white

AZ’s Tagrisso continues successes with EU approval

April 26, 2017
Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …

News
abbviehqe_004_low

AbbVie’s experimental cancer drug hits wall in clinical study

April 20, 2017
Research and Development AbbVie, AstraZeneca

AbbVie have released that two Phase 3 trials of its experimental cancer drug, veliparib, missed both of their primary endpoints. …

News
astrazeneca_sign_sky

AstraZeneca ends month with two pieces of news

March 31, 2017
Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex

AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …

News
astrazeneca_logo_building

AstraZeneca’s medicine approved under China’s Priority Review

March 27, 2017
Sales and Marketing AstraZeneca, Tagrisso, lung cancer

AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under …

News
blood-1813410_960_720

AstraZeneca hit with second blow on $2.7 billion drug

March 17, 2017
Medical Communications AstraZeneca, FDA, hyperkalaemia

AstraZeneca paid $2.7 billion for ZS Pharma, back in 2015, with the desire to get its hands on the company’s …

News

FDA green lights AstraZeneca type-2 diabetes drug

February 28, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA

AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …

News
astrazeneca-sign

AstraZeneca’s hyperkalaemia treatment rebounds with European recommendation

February 24, 2017
Sales and Marketing AstraZeneca, EMA

AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for …

News
currency-166422_960_720

India’s NPPA identifies 634 non-compliant drug pricings

February 24, 2017
Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa

India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …

News
the-chinese-national-flag-1752046_960_720

China’s insurance expansion boon to global pharma

February 23, 2017
Sales and Marketing AstraZeneca, China, GSK, Shire

China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …

News
astrazeneca_logo_building

AstraZeneca sells off cancer drug to TerSera for $250 million

February 20, 2017
Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex

AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025